NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Tablets

Approval Number

国药准字H20184006

Company吉林敖东集团金海发药业股份有限公司

Registration Date

February 14, 2023

Previous Approval Numbers

国药准字H23023409

Drug Information

Generic Name

复方氨酚烷胺片

Dosage Form

片剂

Strength

复方（素片）

Drug Type

化学药品

Registration Date

February 14, 2023

Company Information

Applicant Company

Company Name吉林敖东集团金海发药业股份有限公司

Company Address

吉林省安图县经济开发区兴旺路7号

Manufacturing Company

Company Name吉林敖东集团金海发药业股份有限公司

Company Address

吉林省安图县经济开发区兴旺路7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺片 - NMPA 批准文号 | MedPath